{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T07:32:13Z","timestamp":1775979133333,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":6007,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1038\/labinvest.3700438","type":"journal-article","created":{"date-parts":[[2006,5,8]],"date-time":"2006-05-08T17:35:13Z","timestamp":1147109713000},"page":"781-789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Function-blocking autoantibodies to the melanin-concentrating hormone receptor in vitiligo patients"],"prefix":"10.1016","volume":"86","author":[{"given":"Raju V S R K","family":"Gottumukkala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikos G","family":"Gavalas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samia","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell A","family":"Metcalfe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J","family":"Gawkrodger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W","family":"Haycock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip F","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony P","family":"Weetman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth Helen","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/labinvest.3700438_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/archderm.1977.01640010049006","article-title":"Prevalence of vitiligo: epidemiological survey on the Isle of Bornholm, Denmark","volume":"113","author":"Howitz","year":"1977","journal-title":"Arch Dermatol"},{"key":"10.1038\/labinvest.3700438_bib2","series-title":"Topics in Dermatology","first-page":"257","article-title":"Vitiligo and other hypomelanoses of hair and skin","author":"Ortonne","year":"1983"},{"key":"10.1038\/labinvest.3700438_bib3","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/archderm.1993.01680290066010","article-title":"Pattern of familial aggregation of vitiligo","volume":"129","author":"Majumder","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1038\/labinvest.3700438_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-0625.1993.tb00023.x","article-title":"Review of the etiopathomechanism of vitiligo: a convergence theory","volume":"2","author":"Le Poole","year":"1993","journal-title":"Exp Dermatol"},{"key":"10.1038\/labinvest.3700438_bib5","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/286617a0","article-title":"New regulation of melanin biosynthesis and autodestruction of melanoma cells","volume":"286","author":"Pawelek","year":"1980","journal-title":"Nature"},{"key":"10.1038\/labinvest.3700438_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1001\/archderm.1982.01650130009007","article-title":"Vitiligo. It is important?","volume":"118","author":"Nordlund","year":"1982","journal-title":"Arch Dermatol"},{"key":"10.1038\/labinvest.3700438_bib7","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/1523-1747.ep12492612","article-title":"Low catalase levels in the epidermis of patients with vitiligo","volume":"97","author":"Schallreuter","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1038\/labinvest.3700438_bib8","doi-asserted-by":"crossref","first-page":"935","DOI":"10.7326\/0003-4819-71-5-935","article-title":"Vitiligo in Graves' disease","volume":"71","author":"Ochi","year":"1969","journal-title":"Ann Intern Med"},{"key":"10.1038\/labinvest.3700438_bib9","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1084\/jem.158.1.246","article-title":"Antibodies to normal human melanocytes in vitiligo","volume":"158","author":"Naughton","year":"1983","journal-title":"J Exp Med"},{"key":"10.1038\/labinvest.3700438_bib10","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.188.6.1203","article-title":"High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo","volume":"188","author":"Ogg","year":"1998","journal-title":"J Exp Med"},{"key":"10.1038\/labinvest.3700438_bib11","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0190-9622(86)70260-0","article-title":"Correlation between vitiligo antibodies and extent of depigmentation in vitiligo","volume":"15","author":"Naughton","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/labinvest.3700438_bib12","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/1523-1747.ep12492607","article-title":"Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo","volume":"97","author":"Harning","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1038\/labinvest.3700438_bib13","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/1523-1747.ep12461505","article-title":"Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocyes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity","volume":"90","author":"Norris","year":"1988","journal-title":"J Invest Dermatol"},{"key":"10.1038\/labinvest.3700438_bib14","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/1523-1747.ep12324456","article-title":"In vivo destruction of melanocytes by the IgG fraction of serum from patients with vitiligo","volume":"105","author":"Gilhar","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1038\/labinvest.3700438_bib15","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(94)91709-4","article-title":"The role of tyrosinase in autoimmune vitiligo","volume":"344","author":"Song","year":"1994","journal-title":"Lancet"},{"key":"10.1038\/labinvest.3700438_bib16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1365-2249.1996.d01-727.x","article-title":"Tyrosinase as an autoantigen in patients with vitiligo","volume":"105","author":"Baharav","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1038\/labinvest.3700438_bib17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/1523-1747.ep12276556","article-title":"Detection of tyrosinase autoantibodies in vitiligo patients using 35S-labelled recombinant human tyrosinase in a radioimmunoassay","volume":"109","author":"Kemp","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1038\/labinvest.3700438_bib18","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1046\/j.1365-2133.1998.02503.x","article-title":"Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay","volume":"139","author":"Kemp","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1038\/labinvest.3700438_bib19","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1046\/j.1523-1747.1998.00411.x","article-title":"Anti-tyrosinase-related protein-2 immune response in vitiligo and melanoma patients receiving active-specific immunotherapy","volume":"111","author":"Okamoto","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1038\/labinvest.3700438_bib20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1365-2249.1998.00746.x","article-title":"Autoantibodies to human melanocyte-specific protein Pmel17 in the sera of vitiligo patients: a sensitive and quantitative radioimmunoassay (RIA)","volume":"114","author":"Kemp","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1038\/labinvest.3700438_bib21","doi-asserted-by":"crossref","first-page":"35390","DOI":"10.1074\/jbc.M102391200","article-title":"The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type I","volume":"276","author":"Hedstrand","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.3700438_bib22","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1523-1747.2001.01363.x","article-title":"HLA-A2 restricted, melanocyte-specific CD8+ T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA\/MART1","volume":"116","author":"Lang","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1038\/labinvest.3700438_bib23","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1523-1747.2001.01408.x","article-title":"Specific cytotoxic T lymphocyte responses against MelanA\/MART1, tyrosinase and Gp100 in vitiligo by the use of major histocompatibility complex\/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo","volume":"117","author":"Palermo","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1038\/labinvest.3700438_bib24","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1172\/JCI0214643","article-title":"The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo","volume":"109","author":"Kemp","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1038\/labinvest.3700438_bib25","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1210\/endo.141.12.7833","article-title":"The melanin-concentrating hormone receptor couples to multiple G proteins to activate diverse intracellular signaling pathways","volume":"141","author":"Hawes","year":"2000","journal-title":"Endocrinology"},{"key":"10.1038\/labinvest.3700438_bib26","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0006-291X(02)00932-4","article-title":"Melanin-concentrating hormone and its receptor are expressed and functional in human skin","volume":"296","author":"Hoogduijn","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/labinvest.3700438_bib27","first-page":"788","article-title":"Autoimmune thyroid disease: further developments in our understanding","volume":"15","author":"Weetman","year":"1994","journal-title":"Endocr Rev"},{"key":"10.1038\/labinvest.3700438_bib28","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF02786398","article-title":"Myasthenia gravis as a prototype autoimmune receptor disease","volume":"16","author":"Hoedemaekers","year":"1997","journal-title":"Immunol Res"},{"key":"10.1038\/labinvest.3700438_bib29","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1677\/joe.0.1430527","article-title":"An investigation of the ability of TSH and Graves' immunoglobulin G to increase intracellular calcium in human thyroid cells, rat FRTL-5 thyroid cells and eukaryotic cells transfected with the human TSH receptor","volume":"143","author":"MacNeil","year":"1994","journal-title":"J Endocrinol"},{"key":"10.1038\/labinvest.3700438_bib30","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1677\/joe.0.1570415","article-title":"Differential effect of thyroid-stimulating hormone (TSH) on intracellular free calcium and cAMP in cells transfected with the human TSH receptor","volume":"157","author":"Metcalfe","year":"1998","journal-title":"J Endocrinol"},{"key":"10.1038\/labinvest.3700438_bib31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/08916939708996272","article-title":"Analysis of antibody-dependent cell-mediated cytotoxicity in autoimmune thyroid disease","volume":"25","author":"Metcalfe","year":"1997","journal-title":"Autoimmunity"},{"key":"10.1038\/labinvest.3700438_bib32","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1210\/jcem-60-5-953","article-title":"Blocking type antithyrotropin receptor antibody in patients with nongoitrous hypothyroidism: its incidence and characteristics of action","volume":"60","author":"Arikawa","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/labinvest.3700438_bib33","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1093\/clinchem\/39.10.2053","article-title":"Detection and characterization of blocking-type anti-acetylcholine receptor antibodies in sera from patients with myasthenia gravis","volume":"39","author":"Hara","year":"1993","journal-title":"Clin Chem"},{"key":"10.1038\/labinvest.3700438_bib34","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.tem.2005.05.009","article-title":"Thyrotropin receptor autoantibodies in Graves' disease","volume":"16","author":"Schott","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"10.1038\/labinvest.3700438_bib35","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1210\/jc.2003-031054","article-title":"Activating antibodies to the calcium-sensing receptor in two patients with autoimmune hypoparathyroidism","volume":"89","author":"Kifor","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/labinvest.3700438_bib36","first-page":"700","article-title":"Binding of antithyrotropin receptor autoantibodies in Graves' disease serum to nascent, in vitro translated thyrotropin receptor: ability to map epitopes recognised by antibodies","volume":"81","author":"Morgenthaler","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/labinvest.3700438_bib37","first-page":"2020","article-title":"Detection of binding and blocking autoantibodies to the human sodium-iodide symporter in patients with autoimmune thyroid disease","volume":"85","author":"Ajjan","year":"2000","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/3700438.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/3700438","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722017986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722017986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/3700438.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:42:36Z","timestamp":1758397356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722017986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0023683722017986"],"URL":"https:\/\/doi.org\/10.1038\/labinvest.3700438","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Function-blocking autoantibodies to the melanin-concentrating hormone receptor in vitiligo patients","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/labinvest.3700438","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2006 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}